# Tokenization techniques for privacy-preserving healthcare data: tokenization nuts and bolts

## TL;DR

This paper explains how tokenization helps protect patient privacy in healthcare while enabling secure data integration for research and drug safety monitoring.

## Contribution

The paper highlights tokenization's role in pharmacovigilance and presents real-world applications demonstrating its effectiveness in privacy-preserving data linkage.

## Key findings

- Tokenization enables secure integration of clinical and non-clinical data with over 99% linkage precision.
- Tokenization aligns with international frameworks like the European Health Data Space for regulatory-grade evidence.
- Tokenization may meet de-identification standards, potentially eliminating the need for patient consent in some cases.

## Abstract

Tokenization is a crucial technology for ensuring the security and privacy of patient data in clinical research, pharmacovigilance, and drug safety monitoring. As healthcare increasingly integrates diverse data sources-ranging from clinical records to non-clinical data such as social determinants of health (SDOH)-it is essential to protect sensitive patient information while improving data quality and analysis (National Institutes of Health, 2006). This article emphasizes tokenization’s critical role in safeguarding privacy, particularly in pharmacovigilance activities including safety monitoring, risk assessment, and post-market surveillance. Beyond security, tokenization enriches research datasets by enabling integration of external information, thereby enhancing the rigor and reliability of pharmacovigilance outcomes. With effective tokenization, researchers can better protect patients while gaining deeper insights into clinical and pharmacological research (Cruz et al., 2024). Recent global applications validate tokenization as a foundational privacy-preserving technology in pharmacovigilance. An applied example from a psoriasis clinical trial demonstrated referential tokenization’s capacity to securely link electronic health records (EHRs) and claims data across systems with greater than 99% linkage precision while maintaining privacy standards (D'Andrea et al., 2024). These capabilities align with emerging international frameworks, including the European Health Data Space (2025), reinforcing tokenization’s value in generating regulatory-grade evidence for pharmacovigilance across national and multinational research environments. In many jurisdictions, tokenization that meets de-identification or pseudonymization standards may not require individual patient consent, though this varies based on data sensitivity, jurisdictional law, and the study’s intent (Office for Civil Rights, 2023; EDPB, 2021).